摘要
目的:探讨温补肺肾定喘法治疗慢性阻塞性肺疾病急性加重期的临床疗效及其对肺功能的影响。方法:选取慢性阻塞性肺疾病急性加重期的患者100例,随机分为治疗组和对照组各50例,对照组予西医常规治疗,治疗组在西医常规治疗的基础上,予中药(参蛤散加减)内服,配合穴位外敷冰芥散进行治疗。观察患者临床疗效、12个月内平均复发住院次数及肺功能改善情况。结果:治疗后两组患者FEV1、FVC、FEV1/FCV和FEV1%Pred均较治疗前增高,差异均有统计学意义(P<0.01),且治疗组FEV1、FVC、FEV1/FCV和FEV1%Pred均较对照组高,差异有统计学意义(P<0.05或<0.01)。治疗组患者出院后6个月及12个月内平均复发住院次数均较对照组低,差异有统计学意义(P<0.01)。治疗组总有效率为92.0%,对照组为78.0%,治疗组疗效更优(P<0.05)。结论:加用中药内服配合外敷穴位的温补肺肾定喘法,可明显改善慢性阻塞性肺疾病患者肺功能,增强疗效,减少复发,提高患者的生活质量。
Objective： To investigate the effects of wenbufeishendingchuan （WBFSDC） on Clinical efficacy and pulmonary function of patients with acute exacerbation of chronic obstructive pulmonary disease （AECOPD）. Method： The 100 patients with AECOPD were randomly divided into treatment group and control group, 50 cases each. The control group was treated with conventional western medicine, and the treatment group was given Chinese traditional medicine （Ginseng and Tokay Gecko Pow- der） for oral use and external application of Borneol and white mustard seed powder on acupoint based on routine western medicine. Curative effects, the average times of hospitalization for recurrence in 12 months and pulmonary function were ob- served. Results： After treatment, FEV1, FVC, FEV1/FCV and FEV1% Pred of the two groups both increased （P〈0.01）, and FEV1, FVC, FEV1/FCV and FEV,% Pred in treatment group was higher than those in control group （P〈0.05, P〈0.001）. In 6 months and 12 months post-discharge, the average hospitalized times in treatment group were lower than those in control group （P〈0.01）. The total effective rate was 92.0% in treatment group, better than 75.0% in control group （P〈0.05）. Conclusion： Oral use of WBFSDC combined with external application of Chinese traditional medicine can obviously improve the pulmonary function of patients with COPD, increase the curative efficacy, and reduce the recurrence.
出处
《中医药导报》
2015年第12期66-69,共4页
Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金
惠州市科技计划项目(2013Y243)
关键词
温补肺肾定喘法
慢性阻塞性肺疾病
肺肾气虚
肺功能
Wenbufeishendingchuan
Chronic Obstructive Pulmonary Disease
Insufficiency of QI of the Lung and Kidney
Pulmonary Function
